Interaction
effect
example
{
"resourceType" : "ClinicalUseDefinition",
"id" : "example-interaction",
"extension" : [{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode" : "brr"
}],
"type" : "interaction",
"subject" : [{
"reference" : "MedicinalProductDefinition/example"
"reference" : {
"reference" : "MedicinalProductDefinition/example"
}
}],
"interaction" : {
"interactant" : [{
"itemCodeableConcept" : {
"coding" : [{
"system" : "http://ema.europa.eu/example/interactant",
"code" : "alphaconazole"
}]
}
},
{
"itemCodeableConcept" : {
"coding" : [{
"system" : "http://ema.europa.eu/example/interactant",
"code" : "betaconazole"
}]
}
}],
"type" : {
"coding" : [{
"system" : "http://ema.europa.eu/example/interactionsType",
"code" : "Inhibitor"
}]
},
"effect" : {
"concept" : {
"text" : "Increased plasma concentration"
}
},
"management" : [{
"text" : "Careful monitoring of dose"
}]
}
}
Usage
note:
every
effort
has
been
made
to
ensure
that
the
examples
are
correct
and
useful,
but
they
are
not
a
normative
part
of
the
specification.